Z08

Billable code

Encounter for follow-up examination after completed treatment for malignant neoplasm

The ICD-10 code for encounter for follow-up examination after completed treatment for malignant neoplasm is Z08.

Clinical notes

Excludes1 (not coded here)

An Excludes1 note is a pure exclusion: the excluded condition and this code should never be reported together, because the two conditions cannot occur at the same time (e.g. a congenital form vs. an acquired form of the same disease).

aftercare following medical care (Z43-Z49, Z51)

Also known as

Alternate wording, synonyms, or specific conditions that fall under this code, listed to help confirm you've picked the right one.

Medical surveillance following completed treatment

Use additional code

This code represents an underlying condition. When a related manifestation is also present, coding convention calls for an additional code to be listed after this one.

[object Object]
[object Object]

Documentation support

General coding-documentation guidance — not a substitute for payer-specific requirements or professional coding judgment.

•Confirm the excluded condition(s) listed above are not also present — Excludes1 conditions cannot be coded together with this one.
•If the associated manifestation or related condition noted above is also documented, an additional code should be reported alongside this one.
•As a general rule, code to the highest level of specificity supported by the documentation in the medical record.

Related codes in this category

ICD-9-CM equivalent

Informational only — GEM mappings are approximate, not guaranteed one-to-one equivalents. Verify before use in billing.

V6701Approximate match
V671Approximate match
V672Approximate match
V6759Approximate match
V676Approximate match
V679Approximate match

View full ICD-10 → ICD-9 crosswalk →

Associated MS-DRGs

Z08 can serve as the principal diagnosis for these Medicare Severity Diagnosis-Related Groups.

Informational only — actual DRG assignment also depends on procedures, complications/comorbidities (CC/MCC), discharge status, and payer-specific rules not reflected here.